前收市價 | 330.49 |
開市 | 330.51 |
買盤 | 328.25 x 100 |
賣出價 | 357.29 x 200 |
今日波幅 | 330.45 - 330.95 |
52 週波幅 | 157.00 - 331.58 |
成交量 | |
平均成交量 | 1,114,754 |
市值 | 12.416B |
Beta 值 (5 年,每月) | 0.88 |
市盈率 (最近 12 個月) | 77.45 |
每股盈利 (最近 12 個月) | 4.27 |
業績公佈日 | 2024年8月05日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 316.14 |
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Although the revenue and EPS for Shockwave Medical (SWAV) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.